Company Overview
- Website
- resonantrx.com
- Employees
- 2
- Founded in
- 2015
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
Cancer Focus Fund invests $4.8M into Houston-based March Biosciences
- Nov 9, 2023
- bizjournals.com
Cancer-fighting startup partners with Houston cell therapy accelerator
- Oct 4, 2023
- houston.innovationmap.com
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma
- Apr 3, 2023
- aacrjournals.org
Abstract 3440: Novel in vitro TME platform for rapid cancer therapeutic and target discovery
- Jun 15, 2022
- aacrjournals.org
Resonant Therapeutics Announces Advancement in Collaboration With Janssen
- Sep 16, 2021
- biospace.com
Retrogenix, Resonant Therapeutics partner to identify anti-tumor antibody targets
- Dec 10, 2019
- drugdiscoverytrends.com
Companies Similar to Resonant Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to Resonant Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |